Morgan Stanley maintains Ryan Specialty Holdings at Overweight, raises price target to $55 from $50
Morgan Stanley kept Ryan Specialty Holdings at Overweight, raising its price target to $55 from $50, implying a 17.3% upside from the last close of $46.89. Recent analyst price targets for the company range from $46 to $52.
How this was made

The 30-second read
Why it matters
The analyst upgrade signals confidence in the company's earnings outlook and may prompt short-term buying.
Market read
A fresh price target increase can influence investor sentiment and short-term price action for RYI.
What to watch
Potential exposure to underwriting cycles and macro insurance loss trends.
Background
Ryan Specialty Holdings is a specialty insurance provider listed on NYSE under ticker RYI.
Market effects
May lift other specialty insurance peers as the sector receives a positive analyst note.
Limited to U.S. markets where the stock trades.
Low
Counterpoint
The target raise could be premature if underlying earnings growth does not support the higher valuation.
Key entities
- AnalystMorgan Stanley
Equity research firm that issued the upgraded price target.
- CompanyRyan Specialty Holdings
Specialty insurance firm receiving the upgraded target.


